• XTEND

  Participated · Series B · Jul 2025

  Founded in 2018 by Aviv Shapira, Matteo Shapira, Rubi Liani and Adir Tubi, XTEND builds next-generation autonomous platforms that allow operators to remotely control aerial, ground and maritime drones through its proprietary XOS operating system. The technology is designed to keep personnel out of harm’s way while executing complex, dynamic tasks for defense, public safety and private security customers. XTEND’s field-proven systems are already deployed and the company plans to scale NDAA-compliant domestic manufacturing at its Tampa, Florida facility. Proceeds from its latest transaction will fund accelerated delivery to customers in the United States, NATO member states and Asia. XTEND operates in Israel, the United States and Singapore and will rebrand as XTEND AI Robotics when it lists on Nasdaq. The forthcoming public listing values the company at $1.5 billion. Roughly six months before this deal, XTEND closed a $70 million round jointly led by Protego Ventures and Aliya Capital.

• Momentick

  Led · Seed · Jul 2024

  Momentick develops proprietary algorithms that analyze multi-satellite and drone imagery to detect, quantify, and monitor methane and other greenhouse gas emissions at both facility and large-area scales. The platform offers targeted monitoring for individual energy sites and scalable monitoring across pipeline networks and broad geographic regions. The company was established in 2022 and is led by co-founder and CEO Daniel Kashmir, with Lev Oren as COO and Dr. Ophir Almog as Chief Scientist. Momentick has demonstrated operational results, including identifying multiple emissions and un‑ignited flares at production sites near West Uzbekistan. The business is benefiting from tightening regulation and new EPA fees on methane emissions beginning in 2024, which create demand for frequent inspections and verification. Momentick plans to continue refining its algorithms and expand its emissions intelligence to cover additional harmful gases beyond methane.

• CogniFiber

  Led · Equity · Jul 2024

  CogniFiber is developing DeepLight, a programmable, trainable class of photonic processors that process data at the speed of light by routing signals through multi-core optical fibers. In company demos the Aurora photonic system executed 100 million tasks per second—about 1,000× the throughput of an NVIDIA 100A single network instance—while consuming roughly 180 watts. The startup projects systems capable of up to 50 exaflops with under 5 kilowatts of power by 2027 and says DeepLight can shrink football-field supercomputers to a few server racks while cutting costs, power use, and build time. The new funding will support completion of the first-generation processors and the ongoing development of a photonic supercomputer targeted for market entry in 2027. CogniFiber was founded in 2018, employs 13 people, and has raised $14 million to date including support from the Israel Innovation Authority. CogniFiber is a deep-technology company developing advanced in-fiber photonic processing systems. The company was co-founded by Dr. Eyal Cohen (CEO) and Professor Ze’ev Zalevsky (CTO) and was officially founded in 2018. Before founding the company, the co-founders spent years bringing the technology to life, including working within Intel’s Ingenuity Partner Program. CogniFiber is based in Rosh HaAin, Israel. The firm intends to use proceeds from its Series A to create and deliver a scalable product to market. The company raised $6M in a Series A round led by Chartered Group.

• Trobix Bio

  Led · Series A · Mar 2023

  Trobix Bio develops microbiome-based oncology therapeutics and a proprietary platform that engineers phages as medicines to precisely reprogram targeted gut bacteria for durable therapeutic effects. The company's platform converges computational, synthetic, and synthetic biology technologies to create orally administered cancer supportive‑care products. Its lead program, TBX201, is an oral capsule designed to specifically alter the gut microbiome to reduce the incidence and severity of severe diarrhea caused by irinotecan, a first-line chemotherapy used in over 100,000 patients annually. Trobix aims to reduce life‑threatening gastrointestinal toxicities and enable physicians to complete oncology treatments at optimal doses while improving patient quality of life. Led by CEO Dr. Adi Elkeles, the company intends to use new funding to advance development of its products and proprietary platform technology addressing gastrointestinal side effects of oncology treatments and other microbiome‑impacted GI diseases. Trobix Innovation is a preclinical biotechnology company led by Founder & CEO Dr. Adi Elkeles that develops therapies aimed at removing the threat of antimicrobial resistance. The company leverages its ActiSense™ and GoTrap™ technologies to create phage-based products that deliver DNA to a wide range of bacterial pathogens and actively sensitize them to antibiotics. Its lead product, TBX101, is designed to treat patients carrying gut antimicrobial-resistant bacteria and to restore an antibiotic-sensitive gut microbiome. Trobix intends to use the proceeds from its recent financing to advance its antimicrobial-resistance platform technology and to further pre-clinical development of TBX101. The company is based in Netanya, Israel and operates at the preclinical development stage.

• Hoopo

  Participated · Series A · Aug 2022

  Hoopo develops asset and fleet visibility solutions that track and monitor unpowered assets using power-efficient tracking technology. The company produces long-lasting, highly durable, and affordable tracking units designed to last for an asset’s entire lifetime and provide item-level visibility. Its intelligent location technology is deployed across complex logistics operations, including transportation, aviation, and waste management. Hoopo says customers improve asset utilization, cycle times, and operational efficiency while identifying bottlenecks. The company plans to use new funding to grow in transportation, aviation, and waste management and to develop a maritime tracking solution to transform dry containers into smart, manageable fleets. Hoopo is led by CEO Ittay Hayut and is based in Glil Yam, Israel; to date it has raised $17m. hoopo develops a patent-pending, triangulation-based geolocation solution tailored for low-power wide area (LPWA) IoT networks. Its product suite includes low-cost LPWA gateways and devices plus a management platform that delivers real-time notifications, on-demand geolocation, geofences, and movement alerts. The technology aims to deliver GPS-like precision without the cost or battery consumption of GPS, supporting battery life of up to 10 years in the field. Target use cases highlighted include ports, vehicle dealer yards, parking lots, cattle ranches, and other asset-dense environments. The company launched publicly and announced $1.5 million in funding to further grow the business. hoopo is based in Ra'anana, Israel, and has a presence in Santa Monica, California.

No current team members are available.